Chemical Compound Review:
Halfan 3-(dibutylamino)-1-[1,3- dichloro-6...
Synonyms:
Halofantrina, Halofantrine, Halofantrino, Halofantrinum, CHEMBL1107, ...
- Halofantrine to prevent falciparum malaria on return from malarious areas. Baudon, D., Bernard, J., Moulia-Pelat, J.P., Martet, G., Sarrouy, J., Touze, J.E., Spiegel, A., Lantrade, P., Picq, J.J. Lancet (1990)
- Halofantrine and pruritus. Hallwood, P.M., Horton, R.J., O'Sullivan, K.M., Parr, S.N. Lancet (1989)
- Blackwater fever after halofantrine. Orlando, G., Isabella, L., Atzori, C., Cargnel, A. Lancet (1996)
- Mechanism of cardiotoxicity of halofantrine. Wesche, D.L., Schuster, B.G., Wang, W.X., Woosley, R.L. Clin. Pharmacol. Ther. (2000)
- Food-drug interactions. Schmidt, L.E., Dalhoff, K. Drugs (2002)
- Inhibitors of cAMP-dependent protein kinase impair long-term memory formation in day-old chicks. Zhao, W.Q., Polya, G.M., Wang, B.H., Gibbs, M.E., Sedman, G.L., Ng, K.T. Neurobiology of learning and memory. (1995)
- Efficacy of low-dose halofantrine for second treatment of uncomplicated falciparum malaria. Touze, J.E., Perret, J.L., Nicolas, X., Fourcade, L., Bernard, J., Keundjian, A., Soares, J.M., Doury, J.C. Lancet (1997)
- Effects of artemisinin derivatives on malaria transmissibility. Price, R.N., Nosten, F., Luxemburger, C., ter Kuile, F.O., Paiphun, L., Chongsuphajaisiddhi, T., White, N.J. Lancet (1996)
- Efficacy of multiple-dose halofantrine in treatment of chloroquine-resistant falciparum malaria in children in Kenya. Watkins, W.M., Oloo, J.A., Lury, J.D., Mosoba, M., Kariuki, D., Mjomba, M., Koech, D.K., Gilles, H.M. Lancet (1988)
- Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Cowman, A.F., Galatis, D., Thompson, J.K. Proc. Natl. Acad. Sci. U.S.A. (1994)
- Pharmacokinetic and pharmacodynamic interaction between grapefruit juice and halofantrine. Charbit, B., Becquemont, L., Lepère, B., Peytavin, G., Funck-Brentano, C. Clin. Pharmacol. Ther. (2002)
- Cardiac effects of antimalarial treatment with halofantrine. Nosten, F., ter Kuile, F.O., Luxemburger, C., Woodrow, C., Kyle, D.E., Chongsuphajaisiddhi, T., White, N.J. Lancet (1993)
- Efficacy and pharmacokinetics of intravenous nanocapsule formulations of halofantrine in Plasmodium berghei-infected mice. Mosqueira, V.C., Loiseau, P.M., Bories, C., Legrand, P., Devissaguet, J.P., Barratt, G. Antimicrob. Agents Chemother. (2004)
- Halofantrine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic potential. Bryson, H.M., Goa, K.L. Drugs (1992)
- Postexposure administration of halofantrine for the prevention of malaria. Shanks, G.D., Edstein, M.D., Kereu, R.K., Spicer, P.E., Rieckmann, K.H. Clin. Infect. Dis. (1993)
- Proarrhythmic potential of halofantrine, terfenadine and clofilium in a modified in vivo model of torsade de pointes. Batey, A.J., Coker, S.J. Br. J. Pharmacol. (2002)
- Pharmacokinetics of an extended-dose halofantrine regimen in patients with malaria and in healthy volunteers. Ohrt, C., Watt, G., Teja-Isavadharm, P., Keeratithakul, D., Loesuttiviboon, L., Webster, H.K., Schuster, B., Fleckenstein, L. Clin. Pharmacol. Ther. (1995)
- The anti-malarial drug halofantrine and its metabolite N-desbutylhalofantrine block HERG potassium channels. Mbai, M., Rajamani, S., January, C.T. Cardiovasc. Res. (2002)
- Comparison of the acute cardiotoxicity of the antimalarial drug halofantrine in vitro and in vivo in anaesthetized guinea-pigs. Batey, A.J., Lightbown, I.D., Lambert, J.P., Edwards, G., Coker, S.J. Br. J. Pharmacol. (1997)
- Kinetics of inhibition of glutathione-mediated degradation of ferriprotoporphyrin IX by antimalarial drugs. Famin, O., Krugliak, M., Ginsburg, H. Biochem. Pharmacol. (1999)
- In vitro culture and drug sensitivity assay of Plasmodium falciparum with nonserum substitute and acute-phase sera. Ringwald, P., Meche, F.S., Bickii, J., Basco, L.K. J. Clin. Microbiol. (1999)
- An improved high-performance liquid chromatographic method for the simultaneous measurement of halofantrine and desbutylhalofantrine in human serum. Keeratithakul, D., Teja-Isavadharm, P., Shanks, G.D., Webster, H.K., Edstein, M.D. Therapeutic drug monitoring. (1991)
- Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates. Henry, M., Diallo, I., Bordes, J., Ka, S., Pradines, B., Diatta, B., M'Baye, P.S., Sane, M., Thiam, M., Gueye, P.M., Wade, B., Touze, J.E., Debonne, J.M., Rogier, C., Fusai, T. Am. J. Trop. Med. Hyg. (2006)
- Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells. Traebert, M., Dumotier, B., Meister, L., Hoffmann, P., Dominguez-Estevez, M., Suter, W. Eur. J. Pharmacol. (2004)
- In vitro susceptibility of African isolates of Plasmodium falciparum from Gabon to pyronaridine. Pradines, B., Mabika Mamfoumbi, M., Parzy, D., Owono Medang, M., Lebeau, C., Mourou Mbina, J.R., Doury, J.C., Kombila, M. Am. J. Trop. Med. Hyg. (1999)
- An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: studies with human liver microsomes and heterologous enzyme expression systems. Halliday, R.C., Jones, B.C., Smith, D.A., Kitteringham, N.R., Park, B.K. British journal of clinical pharmacology. (1995)
- Interactions of the antimalarial drug mefloquine with the human cardiac potassium channels KvLQT1/minK and HERG. Kang, J., Chen, X.L., Wang, L., Rampe, D. J. Pharmacol. Exp. Ther. (2001)
- Effect of the antimalarial drug halofantrine in the long QT syndrome due to a mutation of the cardiac sodium channel gene SCN5A. Piippo, K., Holmström, S., Swan, H., Viitasalo, M., Raatikka, M., Toivonen, L., Kontula, K. Am. J. Cardiol. (2001)
- Interference by antimalarial drugs with the in-vitro production of reactive nitrogen intermediates by murine macrophages. Kremsner, P.G., Neifer, S., Rasenack, T., Bienzle, U. J. Antimicrob. Chemother. (1993)
- Clinical pharmacokinetics of halofantrine. Karbwang, J., Na Bangchang, K. Clinical pharmacokinetics. (1994)